Dr. Debottam Sinha is a Research Fellow at the Frazer Institute, The University of Queensland, and an emerging expert in cancer biology. His research focuses on HPV mediated malignancies, addressing unmet clinical needs by identifying molecular vulnerabilities that can be exploited for therapeutic benefit. Dr. Sinha leads multidisciplinary programs aimed at developing novel treatment strategies and generating strong mechanistic and preclinical evidence to support their clinical translation. By integrating multi-omics analyses with advanced 3D tumour models and in vivo systems, his work seeks to provide biologically informed alternative therapeutic options for patients with treatment-resistant disease.